ESMO Breast Cancer 2024: Registration
Late registration deadline: 17 April 2024 at 23:59 (CEST)
Late registration deadline: 17 April 2024 at 23:59 (CEST)
We have noticed an unusual activity from your IP 199.16.157.183 and blocked access to this
Immune cells convert an immunosuppressive lipid into an anticancer immunity enhancer.
Saliby et al. show that a machine learning approach can accurately classify clear cell renal cell carcinoma (RCC) into distinct molecular subtypes using transcriptomic data. When…
Editorial Fellowship Program | Blood | American Society of Hematology .myButton { background-color:#b7000f; border-radius:3px; border:none; display:inline-block; cursor:pointer; color:#fff!important; font-family:Arial; font-size:18px; padding:12px 24px; text-decoration:none; } .myButton:hover…
Dynamic landing page for Patient Guidelines
OCE experts regularly join colleagues to participate in major conferences.
On this page you can find all the information regarding the registration fees, process and applicable terms to attend the EHA2024 Hybrid Congress. Join us…
Jorge J. Nieva, MD, details the benefits of telemedicine and a first-of-its-kind clinical trial where patients with NSCLC will receive subcutaneous immunotherapy at home.
Results from the phase III TRIANGLE trial indicate that the addition of ibrutinib to immunochemotherapy and autologous stem cell transplantation (ASCT) significantly improved failure-free survival…
“I think a virtual nurse can have the same sort of presence that a bedside nurse does. I like to think of a virtual nurse…